Literature DB >> 16061270

Inactivation of enteric adenovirus and feline calicivirus by ozone.

Jeanette A Thurston-Enriquez1, Charles N Haas, Joseph Jacangelo, Charles P Gerba.   

Abstract

Little information is available regarding the effectiveness of ozone on the inactivation of caliciviruses and enteric adenoviruses. Inactivation experiments were conducted with feline calicivirus (FCV), closely related to the human caliciviruses based on nucleic acid organization and capsid architecture, and adenovirus type 40 (AD40). Experiments were carried out in buffered disinfectant demand free water at pH 7 and 5 degrees C. Ct values; concentration of ozone multiplied by contact time with virus; were determined from application of the efficiency factor hom (EFH) model. Ct values for 4-log (99.99%) ozone inactivation at 5 degrees C and pH 7 ranged from 0.07 to 0.60 mg/l min for AD40 and <0.01 to 0.03 mg/l min for FCV. Ct values listed in the US environmental protection agency "Guidance Manual for Compliance with Filtration and Disinfection Requirements for Public Water Systems Using Surface Water Sources" were higher than Ct values generated by this study. Very low ozone residuals (<0.01(mg/l) substantially inactivated FCV and AD40 under the studied conditions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16061270     DOI: 10.1016/j.watres.2005.06.006

Source DB:  PubMed          Journal:  Water Res        ISSN: 0043-1354            Impact factor:   11.236


  20 in total

1.  Inactivation of template-directed misfolding of infectious prion protein by ozone.

Authors:  Ning Ding; Norman F Neumann; Luke M Price; Shannon L Braithwaite; Aru Balachandran; Miodrag Belosevic; Mohamed Gamal El-Din
Journal:  Appl Environ Microbiol       Date:  2011-12-02       Impact factor: 4.792

2.  Ozone generated by air purifier in low concentrations: friend or foe?

Authors:  Larissa Vivan Cestonaro; Ana Maria Marcolan; Luciana Grazziotin Rossato-Grando; Ana Paula Anzolin; Gabriela Goethel; Angélica Vilani; Solange Cristina Garcia; Charise Dallazem Bertol
Journal:  Environ Sci Pollut Res Int       Date:  2017-08-16       Impact factor: 4.223

3.  Kinetics of ozone inactivation of infectious prion protein.

Authors:  Ning Ding; Norman F Neumann; Luke M Price; Shannon L Braithwaite; Aru Balachandran; Gordon Mitchell; Miodrag Belosevic; Mohamed Gamal El-Din
Journal:  Appl Environ Microbiol       Date:  2013-02-15       Impact factor: 4.792

4.  Mechanistic aspects of adenovirus serotype 2 inactivation with free chlorine.

Authors:  Martin A Page; Joanna L Shisler; Benito J Mariñas
Journal:  Appl Environ Microbiol       Date:  2010-03-19       Impact factor: 4.792

5.  Comparison of the effects of formaldehyde and gaseous ozone on HBV-contaminated hospital quilts.

Authors:  Dan Guo; Ziqiong Li; Bei Jia; Xiaoqiong Che; Tianshuang Song; Wenxiang Huang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

6.  Evaluation of murine norovirus, feline calicivirus, poliovirus, and MS2 as surrogates for human norovirus in a model of viral persistence in surface water and groundwater.

Authors:  Jinhee Bae; Kellogg J Schwab
Journal:  Appl Environ Microbiol       Date:  2007-12-07       Impact factor: 4.792

7.  Prevalence and genotypes of human noroviruses in tropical urban surface waters and clinical samples in Singapore.

Authors:  Tiong Gim Aw; Karina Yew-Hoong Gin; Lynette Lin Ean Oon; Eileen Xueqin Chen; Chee Hoe Woo
Journal:  Appl Environ Microbiol       Date:  2009-06-12       Impact factor: 4.792

8.  Characterization of ozone disinfection of murine norovirus.

Authors:  Mi Young Lim; Ju-Mi Kim; Jung Eun Lee; GwangPyo Ko
Journal:  Appl Environ Microbiol       Date:  2009-12-28       Impact factor: 4.792

9.  Inactivation of caliciviruses.

Authors:  Raymond Nims; Mark Plavsic
Journal:  Pharmaceuticals (Basel)       Date:  2013-03-21

10.  Enveloped Virus Inactivation on Personal Protective Equipment by Exposure to Ozone.

Authors:  Emmeline L Blanchard; Justin D Lawrence; Jeffery A Noble; Minghao Xu; Taekyu Joo; Nga Lee Ng; Britney E Schmidt; Philip J Santangelo; M G Finn
Journal:  medRxiv       Date:  2020-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.